Introduction More than 70% of breast cancers are hormone receptor (HR)–positive and human epidermal growth factor receptor 2 (HER2)–negative, with approximately 40% harboring activating phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations that hyperactivate the alpha (α) isoform of phosphatidylinositol 3-kinase
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1007 Reached2 Comments
Treatment of Recurrent Adult Medulloblastoma
2601 Reached1 Comments4 Likes
Black Lesion in Old Female
1972 Reached5 Comments11 Likes
NSCLC Treatment To Control Long-term Tumor Growth
216 Reached1 Comments
Secondary Pseudophakic Malignant Glaucoma
1619 Reached21 Comments12 Likes